REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 222 filers reported holding REATA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $21,016,000 | +38.5% | 134,700 | +28.2% | 0.02% | +20.0% |
| Q1 2020 | $15,170,000 | -69.3% | 105,100 | -56.6% | 0.02% | -60.5% |
| Q4 2019 | $49,493,000 | +788.4% | 242,100 | +143.8% | 0.04% | +533.3% |
| Q4 2018 | $5,571,000 | +249.5% | 99,300 | +409.2% | 0.01% | +200.0% |
| Q3 2018 | $1,594,000 | +43.1% | 19,502 | -44.6% | 0.00% | +100.0% |
| Q2 2017 | $1,114,000 | +99.3% | 35,200 | +42.7% | 0.00% | 0.0% |
| Q1 2017 | $559,000 | – | 24,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |